Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) saw a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 160,700 shares, a decline of 9.1% from the July 31st total of 176,700 shares. Currently, 1.1% of the shares of the company are sold short. Based on an average daily volume of 55,900 shares, the days-to-cover ratio is currently 2.9 days.
Analyst Upgrades and Downgrades
COYA has been the topic of a number of research reports. Chardan Capital reaffirmed a “buy” rating and issued a $14.00 price target on shares of Coya Therapeutics in a report on Wednesday, June 5th. Rodman & Renshaw initiated coverage on shares of Coya Therapeutics in a report on Thursday, June 13th. They issued a “buy” rating and a $18.00 price target on the stock.
Get Our Latest Stock Analysis on Coya Therapeutics
Institutional Inflows and Outflows
Coya Therapeutics Stock Performance
Coya Therapeutics stock traded up $0.09 during mid-day trading on Tuesday, reaching $6.12. The company’s stock had a trading volume of 28,734 shares, compared to its average volume of 67,641. Coya Therapeutics has a 12-month low of $3.21 and a 12-month high of $10.69. The company has a market capitalization of $89.46 million, a P/E ratio of -7.32 and a beta of 0.59. The firm’s fifty day moving average price is $6.36 and its two-hundred day moving average price is $7.77.
Coya Therapeutics Company Profile
Coya Therapeutics, Inc, a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.
Further Reading
- Five stocks we like better than Coya Therapeutics
- How Can Investors Benefit From After-Hours Trading
- 3 Small Cap Stocks That Insiders Are Buying
- 3 Fintech Stocks With Good 2021 Prospects
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for Coya Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coya Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.